People: Safeguard Scientifics Inc (SFE)

SFE on New York Consolidated

16.04USD
19 Jun 2013
Price Change (% chg)

$-0.02 (-0.12%)
Prev Close
$16.06
Open
$16.02
Day's High
$16.23
Day's Low
$15.96
Volume
129,929
Avg. Vol
76,230
52-wk High
$18.00
52-wk Low
$13.15

Search Stocks

Rosenthal, Robert 

Brief Biography

Dr. Robert (Bob) J. Rosenthal, Ph.D. is Independent Director of Safeguard Scientifics Inc. Dr. Rosenthal also is a director of Primera Dx. Positions held include Chairman of the Board and Chief Executive Officer of IMI Intelligent Medical Implants AG, a company that is developing an intelligent retinal implant system for degenerative retinal disorders (January 2010 to present); President, Chief Executive Officer and a director of Magellan Biosciences, Inc., a provider of clinical diagnostics and life sciences research tools (October 2005 to December 2009); President, Chief Executive Officer and a director of TekCel, Ltd., a provider of life sciences research tools (October 2003 to January 2007); President and Chief Executive Officer of Boston Life Sciences, Inc., a diagnostic and therapeutic development company (July 2002 to October 2003); President and Chief Executive Officer of Magellan Discovery Technologies, LLC, a life sciences acquisition company (January 2001 to July 2002); Senior Vice President of PerkinElmer Corporation and President of its instrument division (March 1999 to November 2000); and in various executive positions at Thermo Optek Corporation (September 1995 to February 1999). Dr. Rosenthal holds a BS degree from the University of Maryland, an MS degree from State University of New York, and a PhD degree from Emory University; completed a post-doctoral fellowship at, and was a guest scientist of the Alexander von Humboldt Foundation, followed by an additional post-doctoral fellowship at UCLA; and he holds an AEA Executive MBA degree from Stanford University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Andrew Lietz

--

Stephen Zarrilli

1,049,710

Jeffrey McGroarty

--

Timothy Levy

--

James Datin

1,113,000

Brian Sisko

849,671
As Of 30 Dec 2011
Search Stocks